Program subject to change

Friday 24th March 2017 
Conference Day 1 - Workshops
8:00am - 5:00pm

Ocular Pathology Course

Room: C3.1

Convenor: Hans Grossniklaus

8:00am - 5:00pm

The Second Eye Cancer Working Day

Room: Cockle Bay Room 1 

Convenors: Paul T Finger and Santosh G Honavar

8:00am Registration 8:00am - 8:30am Registration
8:35am - 8:40am


Max Conway and Hans Grossniklaus

8:30am - 8:45am


Paul T Finger

8:40am - 9:00am

Conjunctival Tumors Pathology

Sander Dubovy

8:45am - 9:00am


Santosh G Honavar

9:00am - 10:00am

Comprehensive Open Access Surgical Textbook (COAST)

Convenor: Santosh G Honavar

Faculty: Fairooz P Manjandavida, Carol Shields, Zeynel Karcioglu, Dan Gombos, Paul T Finger, Santosh Honavar, Hardeep Mudhar, Sonal S Chaugule

9:00am - 9:20am

Conjunctival Tumors Clinical

Bertil Damato

9:20am - 9:40am

Uveal Tumors Pathology

Hans Grossniklaus

9:40am - 10:00am

Uveal Tumors Clinical

Carol Shields

10:00am - 11:00am

Radiation Side Effect Registry (RASER)

Convenor: Wolfgang Sauerwein

Faculty: Wolfgang Sauerwein, Paul T Finger, Brenda Gallie

10:00am - 10:20am  
10:20am - 10:30am Panel
10:30am - 11:00am Morning Tea 11:00am - 11:30am Morning Tea
11:00am - 11:20am

Retinoblastoma Pathology

Tero Kivelä

11:30am - 12:30pm

Fellowship Outreach Retinoblastoma (FOR-RB)

Convenor: Ashwin Mallipatna

Faculty: Ashwin Mallipatna, Helen Dimaras, Brenda Gallie, Guillermo Chantada, James Muecke, Nathalie Cassoux, Santosh G Honavar, John Zhao, Yacoub Yousef, Peter Gabel

11:20am - 11:40am

Retinoblastoma Clinical

Matt Wilson

11:40am - 12:00pm

Other Intraocular Tumors Pathology

Ralph Eagle

12:00pm - 12:20pm

Other Intraocular Tumors Clinical

Arun Singh

12:20pm - 12:30pm Panel Discussion
12:30pm - 1:30pm Lunch 
1:30pm - 1:50pm

Ocular/Adnexal Lymphoma Pathology

David Wilson

1:30pm - 2:30pm

Doctor Reported Outcomes (DRO)

Convenor: Tero Kivelä

Faculty: Tero Kivelä and faculty

1:50pm - 2:10pm

Ocular/Adnexal Lymphoma Clinical

Timothy Sullivan

2:10pm - 2:30pm

Lac Gland and Lac Drainage Clinical

Jenny Danks

2:30pm - 2:50pm

Lac Gland and Lac Drainage Pathology

Hardeep Mudhar

2:30pm - 3:30pm

Multicenter International Registries (MIR)

Convenor: Bita Esmaeli

Faculty: Bita Esmaeli, Brenda Gallie, Martine Jager, Zeynel Karcioglou, Yulia Gavrylyuk, Paul T Finger

2:50pm - 3:00pm Discussion
3:00pm-3:30pm Afternoon Tea
3:30pm - 5:00pm Convenor: Hans Grossniklaus 3:30pm - 4:00pm Afternoon Tea
3:30pm - 3:50pm

Orbital Soft Tissue Tumors Clinical

Peter Martin

3:50pm - 4:10pm

Orbital Soft Tissue Tumors Pathology

Svetlana Cherepanoff

4:10pm - 4:30pm

Eyelid Tumors Pathology

Alexandra Allende and Geoff Hall 

4:00pm - 5:00pm

Future Directions: Santosh G Honavar, Martine Jager, Bita Esmaeli, Tero Kivelä, Ashwin Mallipatna, Wolfgang Sauerwein, Paul T Finger

4:30pm - 4:50pm

Eyelid Tumors Clinical

Weng Sehu

4:50pm - 5:00pm Panel Discussion and Conclusion
5:00pm - 6:30pm Welcome Reception, International Convention Centre 

Alcon Dinner*

Hunter Room, Novotel

Discover AcrySof IQ PanOptix Toric
Discover the latest innovation in Presbyopia Correcting technology from Alcon. Designed for more natural adaptability.

Key note speakers and Panel Discussion

*By invitation only. If you would like to receive an invitation please send your contact details to:

Saturday 25th March 2017
Conference Day 2 - Uveal Melanoma
6:45am - 8:00am

Allergan Hosted Breakfast

Cockle Bay 2

Ozurdex® – Management of DMO, Inflammation and Imaging
International Speaker: Hemal Mehta- UK Management of DMO

Australian Speakers: TBC

8:15am - 8:35am

Conference Opening

Welcome to Country – Uncle Chicka Madden

Video presentations – Frank Billson and Peter Lommatzsch

Welcome Address from the ISOO President – Arun Singh

Cockle Bay Room 1

Chair: Michael Giblin

8:35am - 10:00am

Uveal Melanoma Free Paper Session

Chairs: Evangelos Gragoudas & Peter Hadden

8:35am - 8:42am

Molecular classification of uveal melanoma subtypes using integrative mutational and whole-genome copy number analysis

Emine Kilic

8:42am - 8:49am

The prognostic value in uveal melanoma by chromosome 3 and 8q testing is enhanced by adding AJCC staging

Martine Jager

8:49am - 8:56am

Microenvironment regulation of inflammasomes in uveal melanoma favors metastatic growth

Vanessa Morales-Tirado

8:56am - 9:03am

Correlation of COMS-based size categorization and gene expression profile (GEP) sub-classifications in uveal melanoma: a multi-center study

Prithvi Mruthyunjaya

9:03am - 9:10am

Partial Lamellar Sclerouvectomy for Uveal Tumors

Kaan Gunduz 

9:10am - 9:17am

The genetic background of iris melanoma

Natasha van Poppelen

9:17am - 9:24am

Management of suspicious melanocytic lesions of the iris

Evangelos Gragoudas

9:24am - 9:31am

Treatment outcomes for small uveal melanoma

Martina Angi

9:31am - 9:38am

BAP1 germline mutations in Finnish uveal melanoma patients with and without family history

Tero Kivelä

9:38am - 9:45am

Frequency of germline BAP1 mutation in uveal melanoma (UM) patients at risk for a tumor predisposition syndrome (TPDS)

Colleen M Cebulla

9:45am - 9:52am

The use of gene expression profiling as an adjunctive measure to guide the management of indeterminate, high-risk posteriorly located choroidal melanocytic lesions

Kelsey Roelofs

9:52am - 9:59am

Oncolytic adenovirus H101 combined with knocking down GNAQ amplifies the destruction effect of UM cells

Shengfang Ge

10:00am -  10:45am  Morning Tea
10:45am - 12:15pm

Cutaneous Melanoma / Ocular Melanoma

What the ocular oncologist can learn from the study of cutaneous melanoma

Facilitator: Max Conway
10:45am - 11:00am

Systemic drug therapy in melanoma: does subtype matter?

Georgina Long

11:00am - 11:15am

Molecular characterisation of cutaneous melanoma

Richard Scolyer

11:15am - 11:30am

Lessons from cutaneous melanoma for the ocular oncologist 

Hans Grossniklaus

11:30am - 11:45am

Eyelid and conjunctival melanoma, crossing the grey line

Bita Esmaeli

11:45am - 12:00pm

The role of the sentinel lymph node biopsy

Victoria Cohen

12:00pm - 12:15pm

Sentinel node biopsy in cutaneous melanoma

John Thompson AO

12:15pm - 1:15pm Lunch 
1:15pm - 2:25pm

Uveal Melanoma Free Paper Session 

Chairs: Wolfgang Sauerwein and Norbert Bornfeld

1:15pm - 1:22pm

Optical Coherence Tomography Angiography in differential diagnosis between choroidal nevus and melanoma

Alicia Valverde-Megías

1:22pm - 1:29pm

Optical coherence tomography angiography characteristics of iris melanocytic tumors

Alison Skalet

1:29pm - 1:36pm

OCT angiography evaluation of peripapillary vessel density following brachytherapy for uveal melanoma

David Wilson

1:36pm - 1:43pm

Delivered dose uncertainty analysis for partially loaded and eccentrically placed 16 mm COMS plaques compared to fully loaded plaques for brachytherapy treatment of uveal melanoma

Hali Morrison and Ezekiel Weis

1:43pm - 1:50pm

Patient-reported outcomes after treatment of choroidal melanoma: a comparison of Enucleation vs Radiotherapy in 1596 patients

Bertil Damato

1:50pm - 1:57pm

Microincision, 27-gauge aspiration cutter-assisted multifocal iris biopsy for melanoma

Nicole K. Scripsema

1:57pm - 2:04pm

FNAB of choroidal melanoma: Cytopathological analysis of the needle tract

Arun Singh

2:04pm - 2:11pm

Minimal invasive biopsies with 27G vitrector in uveal melanoma advantages/inconvenient

Nathalie Cassoux

2:11pm - 2:18pm

Comparison of cytopathological yield of FNAB of melanocytic uveal tumors diagnosed clinically as uveal melanoma using 25g versus 27g needles

Zélia Corrêa

2:18pm - 2:25pm

Local failure after episcleral brachytherapy for posterior uveal melanoma: patterns, risk factors and management

Claudine Bellerive

2:25pm - 2:45pm

E-Poster Podium Session

Chairs: Carol Shields and Hakan Demirci

2:25pm - 2:28pm

Uveal Melanoma: 5 year update on incidence, treatment, and survival (SEER 1973-2013) 

Mary Beth Aronow

2:28pm - 2:31pm

Uveal melanoma and renal cell carcinoma in the same patient: 24 Finnish cases

Tero Kivelä

2:31pm - 2:34pm

UM Cure 2020 - A Consortium of European experts in Uveal Melanoma to identify new therapies for patients with metastatic disease

Martine J Jager

2:34pm - 2:37pm

Choroidal Melanoma metastatizing 19 years from the first diagnosis and EBR treatment and 14 years after enucleation for two metachronous tumors on the opposite side of primary site

Vincenzina Mazzeo

2:45pm - 3:15pm Afternoon Tea
3:15pm - 5:00pm

Uveal Melanoma Short Case Session

Chairs: John McKenzie and Scott Oliver

3:15pm - 3:20pm

Genetic analyses of multifocal uveal melanoma

Brian Marr

3:20pm - 3:25pm

Intratumoral oncolytic therapy for metastatic uveal melanoma

Sapna Patel

3:25pm - 3:30pm

Multifocal choroidal melanoma in a patient with germline BAP1 mutation

Raksha Rao

3:30pm - 3:35pm

A suspicious conjunctival mass 27 years after iris tumour resection

Ido Didi Fabian

3:35pm - 3:40pm

Immune response to melanoma

Michael Goldbaum

3:40pm - 3:45pm

Diffuse choroidal melanocytoma masquerading as diffuse choroidal melanoma

Santosh G Honavar

3:45pm - 3:50pm

Selective intra-arterial embolization for advanced extrascleral uveal melanoma

Victor Villegas

3:50pm - 3:55pm

Case report of 2 patients with massive vitreous seeding in choroidal malignant melanoma: A rare presentation, treated with combined tumor endoresection and Ruthenium (Ru-106) brachytherapy as the alternative treatment to enucleation

Duangnate Rojanaporn

3:55pm - 4:00pm

A young woman with an old person's tumor

Maria Pefkianaki

4:00pm - 4:05pm

Sympathetic ophthalmia associated with untreated choroidal melanoma

Deepa Viswanathan

4:05pm - 4:10pm

Review of the distribution of DNA alterations identified by our uveal melanoma (UM) prognostic assay

Jaime Jessen

4:10pm - 4:15pm 

Choroidal melanoma with secondary orbital cellulitis

Hamish Dunn

4:15pm - 4:20pm

Rhegmatogenous retinal detachment in a patient with choroidal melanoma simulating choroidal detachment

Satoru Kase

4:20pm - 4:25pm

Uveal melanoma in an indigenous Polynesian patient

Peter Hadden

4:25pm - 4:30pm

Limbal stem cell preservation during proton beam irradiation for diffuse iIris melanoma

Claudine Bellerive

4:30pm - 4:35pm

Bilateral macula uveal melanoma

Jasmine Francis

4:35pm - 4:40pm

Bilateral diffuse and bilateral multifocal uveal melanoma

Andrey Yarovoy

4:40pm - 4:45pm

Presumed bilateral ICE syndrome diagnosed as bilateral iris melanoma

Vincenzina Mazzeo

4:45pm - 4:50pm

Annular ciliary body melanoma?

Arturo Irarrazaval

4:50pm - 4:55pm

6 cases of presumed spontaneous necrosis of iris melanoma: clinical and ultrasound biomicroscopy findings

John McWhae

4:55pm - 5:00pm

C-B Choroidal Malignant melanoma masquerading as granuloma in a young child

Vicktoria (Vicky) Vishnevskia-Dai

5:00pm - 5:05pm


Michael Seider

6:30pm - 8:30pm ISOO Cocktail Reception, Museum of Contemporary Art
Sunday 26th March 2017
Conference Day 3 - Ocular Melanoma / Other Intraocular Tumours / Retinoblastoma
8:30am - 9:35am

Uveal Melanoma  Free Paper Session 

Room: Cockle Bay Room 1

Chairs: Duangnate Rojanaporn and Zelia Correa

8:30am - 8:37am

Management of choroidal neovascular membranes associated with choroidal nevi

Hakan Demirci

8:37am - 8:44am

Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma

Victoria Cohen

8:44am - 8:51am

Asymmetric loading of Iodine-125 radioactive plaques in the treatment of uveal melanoma

Wantanee Dangboon

8:51am - 8:58am

Regression of Iris Melanoma after Palladium-103 (103Pd) Plaque Brachytherapy

Sonal S Chaugule

8:58am - 9:05am

Long-term follow-up of a 24-month study of ranibizumab for the prevention of radiation vasculopathy

Ivana K. Kim

9:05am - 9:12am

Uveal melanoma-associated mortality within the Scottish Ocular Oncology Service

Vikas Chadha

9:12am - 9:19am

Endoresection technique and outcomes in the management of posterior choroidal melanoma

Bryan Matthews

9:19am - 9:26am

Uveal melanoma recurrence, treatment and outcomes

Brian Marr

9:35am - 10:00am


Screening for and treatment of metastatic uveal melanoma

Coordinator: Steffan Seregard

9:35am - 9:40am

Screening for metastatic uveal melanoma

Bertil Damato

9:40am - 9:45am

Screening for metastatic uveal melanoma

Stefan Seregard

9:45am - 9:50am

Treatment of metastatic uveal melanoma

Anthony Joshua

9:50am - 9:55am

Management of metastatic uveal melanoma at Thomas Jefferson University

Takami Sato

10:00am - 10:30am  Morning Tea
10:30am - 11:50am

Uveal Melanoma Free Paper Session

Chairs: William Campbell and Paul Finger

10:30am - 10:37am

Telephone (early) versus examination (late) disclosure of prognostic uveal melanoma results: Associations with anxiety and depression

Jaime Jessen

10:37am - 10:44am

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

Sapna Patel

10:44am - 10:51am

Population cluster in uveal melanoma

Miguel Materin

10:51am - 10:58am

Transpupillary thermotherapy for treatment of tumor edge recurrence of choroidal melanoma post brachytherapy

Yael Chavez

10:58am - 11:05am

CANT1 lncRNA triggers efficient anti-tumor efficacy by targeting aberrant lncing cascade in uveal melanoma

He Zhang

11:05am - 11:12am

Radiation maculopathy and optic neuropathy risk associated to baseline clinical features of uveal melanoma prior to I-125 plaque brachytherapy

Victor Villegas

11:12am - 11:19am

Uveal melanoma in the only seeing eyes

Andrey Yarovoy

11:19am - 11:26am

106Ru – plaque radiotherapy for large uveal melanomas

Anush Amiryan

11:50am - 12:10pm

Invited Speaker Session

Chair: William Glasson


Differences in genomic landscape of uveal and cutaneous melanoma: implications for targeted treatments

Nick Hayward


Melanoma and the Hippo pathway

Mark Shackleton 

12:10pm - 12:31pm

Ocular Melanoma / Other Intraocular Tumours Free Paper Session

Chairs: William Glasson & Noel Horgan

12:10pm - 12:17pm

Mushroom shaped choroidal lesions other than melanoma

Jerry Shields

12:17pm - 12:24pm

Treating vitreoretinal lymphoma by intravitreal methotrexate, 20 years of experience

Jacob Pe'er

12:24pm - 12:31pm

Intraocular metastases secondary to breast carcinoma: identification of a specific molecular subtype associated with choroidal involvement

Raffaele Parrozzani

12:45pm - 1:45pm Lunch 
1:45pm - 2:18pm

Ocular Melanoma / Other Intraocular Tumours Free Paper Session

Chairs: Hiroshi Goto & Prithvi Mruthynjaya

1:45pm - 1:52pm

Fine needle aspiration for suspected ocular metastases

Charles Biscotti

1:52pm - 1:59pm

Ruthenium-106 brachytherapy in the treatment of circumscribed choroidal hemangioma

Masood Naseripour

1:59pm - 2:06pm

Leaky Choroidal Nevi: A clinical, imaging and therapeutic analysis

Shahar Frenkel

2:06pm - 2:13pm

Simple treatment for Circumscibed Choroidal Hemangioma

Arturo Irarrazaval

2:15pm - 3:00pm

Ocular Melanoma / Other Intraocular Tumours Short Case Session

Chairs: Sachin Salvi and Tero Kivelä

2:15pm - 2:20pm

Sirolimus for treatment of large astrocytic hamartoma in a patient with tuberous sclerosisIvana

Ivana K Kim

2:20pm - 2:25pm

Isolated choroidal amyloidoma mimicking an intraocular tumour

Mandeep Sagoo

2:25pm - 2.30pm

A slowly growing optic nerve mass in an adolescent: Case Report

Wantanee Dangboon

2.30pm - 2.35pm

A Puzzling Pale Choroidal Mass

Jennifer Chao

2.35pm - 2.40pm

Outer Space Tumor

Carol Shields

2.40pm - 2.45pm

An alternative management for diffuse choroidal hemangioma in a child

Zélia M Corrêa

2.45pm - 2.50pm

Uveal metastasis from prostate carcinoma: 3 cases in 6 months in a single institution

Jenna Kim

2.50pm - 2.55pm

Mystery Case

Mary Beth Aronow

2.55pm - 3.00pm

Venetoclax can cause central serous-like chorioretinopathy

Shahar Frenkel

3.00pm - 3.30pm Afternoon Tea
3:30pm - 4:05pm

Ocular Melanoma / Other Intraocular Tumours Short Case Session 

Chairs: Bertil Damato and Vicktoria (Vicky) Vishnevskia-Dai

3:30pm - 3:35pm

Mystery Case

Masood Naseripour

3:35pm - 3:40pm

Combined type Ⅰ and type Ⅱ neurofibromatosis in a case

Hongshu Zhao

3:40pm - 3:45pm

Melanoma-associated vitelliform retinopathy: a clinical case

Svetlana Saakyan

3:45pm - 3:50pm

Mystery Case

Jerry A Shields

3:50pm - 3:55pm

Choroidal metastasis from lung cancer treated by iodine-125 brachytherapy

Yue Ming Liu

4:15pm - 5:30pm

Retinoblastoma Free Paper Session 

Chairs: John Hungerford and Fiarooz Puthiyapurayil Manjandavida

4:15pm - 4:22pm

Rabbit model of intra-arterial chemotherapy: Technique, vascular variations, pharmacokinetics, and toxicities

Anthony B Daniels

4:22pm - 4:29pm

Extracellular matrix remodelling in an Etoposide resistant subclone derived from WERI-Rb1

Vinodh Kakkassery

4:29pm - 4:36pm

Rabbit model of indirect photodynamic therapy for retinoblastoma

Jonathan Kim

4:36pm - 4:43pm

Evaluation of the toxicity of Intravitreal carboplatin injection in a rabbit model

Vicktoria (Vicky) Vishnevskia-Dai

4:43pm - 4:50pm

A novel antiangiogenic therapy decreases tumor burden in a retinoblastoma mouse model

Timothy Corson

4:50pm - 4:57pm

Prognostic significance of nuclear survivin (BIRC5) in retinoblastoma

Kaustubh Mulay

4:57pm - 5:04pm

The PDGF-PDGFR signaling pathway as a potential targeted therapy to reduce retinoblastoma cell survival and increase apoptosis

Matthew Wilson

5:04pm - 5:11pm

Identifying invasion-promoting molecular pathways in retinoblastoma

Laura Asnaghi

5:11pm - 5:18pm

Using droplet digital polymerase chain reaction (ddPCR) to confirm and validate copy number variants (CNVs) and low level mosaic single nucleotide variants (SNV) identified from RB1 next generation sequencing (NGS)

Hilary Racher

Monday 27th March 2017
Conference Day 4 - Retinoblastoma 
8.30am - 9:31am

Retinoblastoma Free Paper Session

Room: Cockle Bay Room 1

Chairs: Ashwin Reddy and Anamika Patel

8.30am - 8.37am

The incidence of visual impairment and blindness in retinoblastoma

Andrew W Stacey

8.37am - 8.44am

Resection of Refractory Intraocular Retinoblastoma

Junyang Zhao

8.44am - 8.51am

The Expanding Uses of Intravitreal Melphalan

David Abramson

8.51am - 8.58am

Intravenous chemotherapy for retinoblastoma causes reduction in deep capillary density on optical coherence tomography angiography

Carol Shields

8.58am - 9.05am

Clinical outcome of Multi-modal Therapy in Extra-ocular Retinoblastoma with optic nerve invasion

Bhavna Chawla

9.05am - 9.12am

Super selective intra-arterial chemotherapy in retinoblastoma:  initial experience  from a tertiary care institute of north India

Usha Singh

9.12am - 9.17am

Methods of regional chemotherapy, depending on the anatomical variants of the blood supply to the eye, at the selective ophthalmic arterial infusion (SOAI) at children with the intraocular retinoblastoma

Igor Trofimov

9.17am - 9.24am

Superselective intra-arterial chemotherapy for retinoblastoma: first 5-year experience from two referral centers in Brazil

Luiz Fernando Teixeira

9.24am - 9.31am

Recovery of foveal microanatomy after intravenous or intraarterial chemotherapy for foveolar retinoblastoma: correlation with clinical features at presentation and visual outcomes in 104 eyes

Christina Stathopoulos

9:31am - 10:00am


Optimum treatment for retinoblastoma group D eyes: IAC, IVC or intravitreal chemotherapy

Coordinator: Hayyam Kiratli 

9.31am - 9.35am David Abramson
9.35am - 9.40am Brenda Gallie
9.40am - 9.45am Nathalie Cassoux
9.45am - 9.50am Matt Wilson
9.50am - 9.55am Hayyam Kiratli
9:55am - 10:00am Discussion
10.00am -  10.30am Morning Tea
10.30am - 11.00am

Stallard Lecture

Chair: John Hungerford

Pigmented Lesions of the Conjunctiva

Ralph Eagle

11.00am - 11.20am

Judith Kingston Lecture

Chair: John Hungerford

Recent developments in intravitreal therapy in retinoblastoma

Francis Munier

11.20am - 12.02pm

Retinoblastoma Free Paper Session 

Chairs: Maria Manquez & Jerry Shields

11.20am - 11.27am

High-risk histopathology features in primary and secondary enucleated international classification of retinoblastoma group D Eyes

Mandeep Sagoo

11.27am - 11.34am

Intravitreal anti-VEGF enables globe salvage in retinoblastoma eyes developing secondary neovascularization

Marie-Claire Gaillard

11.34am - 11.41am

Ophthalmic screening of children at risk for retinoblastoma: consensus statement from the American Association of Ophthalmic Oncologists and Pathologists (AAOOP)

Dan Gombos

11.41am - 11.48am

Carrier risk for parents of children with non-familial retinoblastoma

Brenda L Gallie

11.48am - 11.55am

Intra-arterial Chemotherapy versus Intravenous Chemotherapy for Unilateral Retinoblastoma.  Who wins?

Carol Shields

11.55am - 12.02pm

A Comparison of Vitreous Seed Clouds (class 3) treated with Ophthalmic Artery Chemosurgery with or without Intravitreous Chemotherapy

Jasmine Francis

12:10pm - 1:10pm Lunch 
1:10pm - 2:45pm

Retinoblastoma Free Paper Session

Chairs: Michael Jones and Francis Munier

1:10pm - 1:17pm

Primary enucleation for Group D retinoblastoma in the era of conservative systemic and targeted chemotherapy: the price of retaining an eye

Ido Didi Fabian

1:17pm - 1:24pm

Long-term results following intraocular surgery in unsuspected retinoblastoma eyes

Norbert Bornfeld

1:24pm - 1:31pm

Histopathology of enucleated retinoblastoma  eyes prior intraarterial chemotherapy with  focus on vascular treatment toxicity and tumour control

Eva Biewald

1:31pm - 1:38pm

Treatment outcomes of focal laser consolidation during chemoreduction for Group B retinoblastoma

Jonathan Kim

1:38pm - 1:45pm

Benchmarking retinoblastoma service delivery: The Australasian experience

John McKenzie

1:45pm - 1:52pm

Primary and secondary cavitary retinoblastoma tumours: identification, management and genetic analysis

M. Ashwin Reddy

1:52pm - 1:59pm

Genetic mutation analysis of retinoblastoma tumor cells and its relation with previous treatment

Shigenobu Suzuki

1:59pm - 2:06pm

Retinoblastoma in Thailand: Report from tertiary referral center

Duangnate Rojanaporn

2:06pm - 2:13pm

Risk of Metastasis and Orbital Recurrence in Advanced Retinoblastoma Eyes Treated with Systemic Chemoreduction versus Primary Enucleation

Jesse Berry

2:13pm - 2:20pm

High-risk histopathologic features in RB: Analysis of 876 primarily enucleated eyes from Beijing Tongren Hospital

Xiaolin Xu

2:20pm - 2:27pm

Retinoblastoma presenting as Preseptal and Orbital Cellulitis: A study of 80 consecutive cases

Prerana Tahiliani

2:27pm - 2:34pm

Clinical presentations and outcomes of Asian Indian patients presenting with retinoblastoma at one or less than one year of age

Anamika Patel

2:34pm - 2:41pm

Clinical presentation and treatment outcome of Retinoblastoma children in National Eye Centre Cicendo Eye Hospital, Indonesia 2012-2016

Mayasari Kuntorini

2:45pm - 3:15pm Afternoon Tea
3:15pm - 3:55pm

Retinoblastoma Short Case Session

Chairs: Glen Gole and Ralph Eagle

3:15pm - 3:20pm

Asymptomatic cerebral ischemic event following intra-arterial administration of chemotherapy for retinoblastoma

Dan Gombos

3:20pm - 3:25pm

Preferred Retinal Locus (PRL) in a child with retinoblastoma and a macular tumour

M. Ashwin Reddy

3:25pm - 3:30pm

Retinocytoma in a child with a large deletion in the RB1 Gene. A case report

Jacob Pe'er

3:30pm - 3:35pm

RB1 cDNA mutation screening in a hereditary case of unilateral retinoblastoma reveals aberrant mRNA splicing and facilitates detection of a deep intronic substitution

Hilary Racher

3:35pm - 3:40pm

OCT guided sequential targeted laser therapy in juxtafoveal retinoblastoma

Sameh Soliman

3:40pm - 3:45pm

Protective eyewear in patients with retinoblastoma: Time to rethink

Masood Naseripour 

3:45pm - 3:50pm

Atypical presentation of bilateral retinoblastoma with vitreous floaters and sub-internal limiting membrane floccular deposits in an 11-year-old Asian Indian male

Pukhraj Rishi

3:50pm - 3:55pm

Case report: retinoblastoma or Coats?

Junyang Zhao

3:55pm - 4:13pm

Retinoblastoma E-Poster Podium Session

Chairs: Kaustubh Mulay and  Shigenobu Suzuki

3:55pm - 3:58pm

Clinical and genetic features of retinoblastoma

Tatiana Ushakova

3:58pm - 4:01pm

Evaluation of SYK protein expression in treated versus untreated retinoblastoma

Sameh Soliman

4:01pm - 4:04pm

Superselective intra-arterial chemotherapy for group D Retinoblastoma eyes

Luiz Fernando Teixeira

4:04pm - 4:07pm

Selective ophthalmic arterial injection therapy for refractory retinoblastoma: A two-year single-center study in China

Jing Zhang

4:07pm - 4:10pm

Management of Bilateral Retinoblastoma in the Intrarterial Era at MSKCC (2011-2016)

Jasmine Francis

4:10pm - 4:13pm

Magnetic resonance imaging features of the optic nerve in retinoblastoma patients after enucleation

Jonathan Kim

4:30pm - 6:00pm ISOO Business Meeting
7:00pm - 11:00pm Conference Dinner, Sydney Eye Hospital
Tuesday 28th March 2017
Conference Day 5 - Conjunctiva/eyelids/orbit
8:30am - 9:00am

Invited Speaker Session

Room: Cockle Bay Room 1

Chairs: Mandeep Sagoo and Victoria Cohen

8:30am - 8:45am

Conjunctival Melanoma

Max Conway

8:45am - 9:00am

Conjunctival Squamous Neoplasia: Magic Potions, Tricks and Double Trouble

Carol Shields

9:00am - 10:03am

Conjunctiva / Eyelids / Orbit Free Paper Session

Chairs: James Muecke AM and Miguel Materin

9:00am - 9:07am

Novel laser photocoagulation of ocular surface squamous neoplasia

Rubens Belfort

9:07am - 9:14am

Ruthenium 106 (106Ru) Plaque Brachytherapy in the management of Ocular Surface Squamous Neoplasia (OSSN) with Scleral Invasion

Santosh G Honavar

9:14am - 9:21am

Concomitant primary simple limbal epithelial transplantation after surgical excision of ocular surface squamous neoplasia prevents limbal stem cell deficiency: A case-control study

Swathi Kaliki

9:21am - 9:28am

Retrospective analysis of the recurrence rate and complications associated with different topical mitomicin C regimens for the treatment of Ocular Surface Squamous Neoplasia

Jim McAlister

9:28am - 9:35am

Topical 5-Fluorouracil following surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-masked, placebo-controlled trial

Stephen Gichuhi

9:35am - 9:42am

Intraoperative monitoring of radical surgical excision of conjunctival and iris tumors

Svetlana Saakyan

9:42am - 9:49am

Innovative use of intralesional interferon for chemoreduction of ocular surface tumours at first presentation

Soyang Ella Kim

9:49am - 9:56am

Stereotactic radiosurgery in the management of ocular surface tumours invading into the anterior orbit

Sachin Salvi

9:56am - 10:03am

Orbital Extra-medullary Granulocytic Sarcoma (Chloroma)

Puneet Jain

10.03am - 10:30am


The role of chemotherapy / immunotherapy for conjunctival melanoma

Coordinator: Jacob Pe'er

10:03am - 10:08am Jacob Pe'er
10:08am - 10:13am James Muecke AM
10:13 am - 10:18am

Treatment of conjunctival tumours

Raffaele Parrozzani 

10:18am - 10:23am Dan Gombos
10:30am - 11:00am Morning Tea
11:00am - 11:10am

Conjunctiva / Eyelids / Orbit E-Poster Podium Session

Chairs: Brian Marr and Karin Lecuona

11:00am - 11:03am

Meningioma and melanoma in patients with Turner Syndrome

RJW De Keizer

11:03am - 11:06am

In vivo confocal microscopic study with histopathologic correlation in intraepithelial  conjunctival neoplasia

Carolina Gentile

11:06am - 11:09am

Topical 5 Fluorouracil 0:5% for Ocular Surface Squamous Neoplasia: an study of efficacy and safety of treatment in Brazil

Priscilla Ballalai

11:10am - 11:40am

Invited Speaker Session

Chairs: Brian Marr and Karin Lecuona

11:10am - 11:25am


Timothy Sullivan

11:25am - 11:40am

Sebaceous gland carcinoma

Santosh G Honavar

11:40am - 12:50pm

Conjunctiva / Eyelids / Orbit Free Paper Session 

Chairs: Svetlana Cherapanoff and Colleen Cebulla

11.40am - 11.47am

A clinicopathological study on IgG4-related ophthalmic disease

Yuka Suimon

11.47am - 11.54am

Ultra low dose radiation (4Gy) for Orbital and Ocular Adnexal Lymphoma

Bita Esmaeli

11.54am - 12.01pm

Breaching the capsule; biopsy in lacrimal gland pleomorphic Adenomas and risk of recurrence

James Sterrey

12.01pm - 12.08pm

Case Series of Primary Orbital Sarcomas

Manvi Sobti

12.08pm - 12.15pm

Clinical findings and clinical courses of IgG4 producing MALT lymphoma

Koh-ichi Ohshima

12:15pm - 12:21pm

Usefulness of flow cytometry in diagnosis of extranodal marginal zone B-cell lymphoma of the ocular adnexa

Satoru Kase

12:21pm - 12:28pm

Primary malignant neoplasms of the lacrimal gland: Clinical features and outcome in 66 patients


12:28pm - 12:35pm

Neoadjuvant cryotherapy for periocular sebaceous carcinoma

Brian Marr

12:35pm - 12:42pm

Comparison of posterior lamellar resection versus non-posterior lamellar resection for localized tarsal conjunctival sebaceous carcinoma in 54 cases

Raksha Rao

12:42pm - 12:49pm

Exenteration and single stage repair of the orbital socket using a temporalis muscle flap in the management of ocular and eyelid tumors

Stephanie Lemaitre

12:50pm - 2:25pm

Conjunctiva / Eyelids / Orbit Short Case session

Chairs: Luiz Teixeira & Raffaele Parrozzani

12:50pm - 12:55pm

Ocular surface epithelial atypia mimicking squamous neoplasia in association with ulcerative colitis

Prithvi Mruthyunjaya

12:55pm - 1:00pm

Metastatic tarsal conjunctival placental site trophoblastic tumour (PSTT)

Hardeep Singh Mudhar

1:00pm - 1:05pm

Isolated eyelid Rosai-Dorfman disease: A rare eyelid tumor

Swathi Kaliki

1:05pm - 1:10pm

So-called 'malignant mesenchymoma' (composite sarcoma) of the orbit: a rare and perplexing pediatric tumor

Kaustubh Mulay

1:10pm - 1:15pm

Surgical drainage of lymphangiectasia haemorrhagica conjunctivae

Arun Singh

1:15pm - 1:20pm

Neoadjuvant chemotherapy  in Sebaceous Gland Carcinoma with orbital extension

Prerana Tahiliani

1:20pm - 1:25pm

Atypical Teratoid Rhabdoid tumour

Puneet Jain

1:25pm - 1:30pm

Sonic hedgehog inhibitors for treatment of locally advanced basal cell carcinoma of periocular region

Bita Esmaeli

1:30pm - 1:35pm

Conjunctival tumor

Miguel Materin

1:35pm - 1:40pm

Oral propanolol in the management of periocular Infantile capillary Hemangioma-initial results

Usha Singh

1:40pm - 1:45pm

Orbital melanoma in a patient with oculodermal melanocytosis: clinical, instrumental, morphological and molecular genetics examination (a case report)

Anush Amiryan

1:45pm - 1:50pm

Conjunctival melanoma during pregnancy

Ranaa Al Jamal

1:50pm - 1:55pm

Malignant transformation of a multi-operated divided nevus of the eyelids

Stephanie Lemaitre

1:55pm - 2:00pm

Concomitant orbital cavernous hemangioma and schwannoma in a patient: A rare presentation


2:00pm - 2:05pm

Acute large proptosis in an African American female patient: Case report

Yael Chavez

2:05pm - 2:10pm

Multimodal Management in a case of Primary Orbital Atypical Teratoid Rhabdoid Tumor

Sonal S Chaugule

2:10pm - 2:15pm

Solitary isolated neurofibroma of the conjunctiva

Ranaa Al Jamal

2:15pm - 2:20pm

Surgical Navigation Assisted Endoscopic Orbital Surgery in the Management of Thyroid Ophthalmopathy

Kaan Gunduz

2:20pm - 2:30pm  Conference Close

© Copyright 2015. Site by Invisage